{
  "pmcid": "5831461",
  "sha256": "b4605c66ee5bf46ece41503f7d0ed019ada3574b8fdd6717797c4fd8fb34dff1",
  "timestamp_utc": "2025-11-09T16:05:53.155000+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.874596774193552,
    "reading_ease": 11.425228494623695,
    "word_count": 310
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This study was a multicenter, double-blind, randomized, placebo-controlled trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This study was a multicenter, double-blind, randomized, placebo-controlled trial that randomly assigned patients to dexmedetomidine or saline placebo"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were elderly (>68 years) patients undergoing major elective noncardiac surgery."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Dexmedetomidine infusion (0.5 µg/kg/h) during surgery and up to 2 hours in the recovery room."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: To evaluate whether an intraoperative infusion of dexmedetomidine reduces postoperative delirium."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Patients were assessed daily for postoperative delirium (primary outcome)"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomly assigned patients to dexmedetomidine or saline placebo"
      },
      "Blinding": {
        "score": 2,
        "evidence": "double-blind"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "In total, 404 patients were randomized; 390 completed in-hospital delirium assessments"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "390 completed in-hospital delirium assessments"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "There was no difference in postoperative delirium between the dexmedetomidine and placebo groups (12.2% [23 of 189] vs 11.4% [23 of 201], P = .94)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were comparably distributed in the treatment groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial Registration: clinicaltrials.gov Identifier NCT00561678"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}